Home Blog Page 1099

Euronext Amsterdam listed SWI Stoneweg Icona Group moves into AI compute with majority investment in Polarise, a leading European NVIDIA Cloud Partner, creating a fully integrated European AI infrastructure platform

By
Advertorial Desk
-

–  SWI Stoneweg Icona Group has agreed to acquire a majority position in Polarise, a leading European NVIDIA Cloud Partner

–  The deal will further strengthen SWI Group’s data center and AI strategy through the addition of GPU-as-a-Service and AI-as-a-Service capabilities to SWI’s own 2.3 GW AiOnX data centre platform

–  Polarise’s valuation set at EUR 0.5 billion once the SWI Group investment completes

–  SWI commits EUR 1.0 billion to grow Polarise’s digital infrastructure strategy

–  The transaction gives Polarise full infrastructure and financial backing to foster its expansion and create a major European AI digital infrastructure player

LONDON, Feb. 24, 2026 /PRNewswire/ — SWI Stoneweg Icona Group has agreed to acquire a majority stake in Polarise, a European NVIDIA Cloud Preferred Partner, (including a EUR 100 million equity investment for operations), marking a natural extension of the Group’s data centre strategy into AI compute. The transaction brings GPU- and AI-as-a-Service capabilities onto the AiOnX platform and supports SWI Group’s focus on building scalable, income-generating digital infrastructure across Europe.”

The transaction will capitalize the combined knowledge and experience of the respective teams, while seeking to roll out additional capabilities and expedite new pipeline execution with strategic hires across key functions.

Based in Germany, Polarise is a one-stop AI digital infrastructure provider with a focus on building the underlying infrastructure for AI and providing high-performance computing (HPC) capacities via its hardware and software offerings. Polarise is both a Preferred NVIDIA Partner, and also an official NVIDIA Cloud Service Provider. Polarise has recently launched the first industrial-scale AI Factory in Germany in partnership with Deutsche Telekom and NVIDIA, following their first AI factory in Oslo, Norway. Polarise focus on delivering best-in-class services to leading Enterprise and Sovereign AI computing requirements, backed by 15 years of experience.

This new partnership will secure all future financial requirements to expand the offering of Polarise and it will leverage AiOnX’s 2.3GW existing Europe-wide platform to rapidly expand compute deployment across the continent and gain market presence in other European countries.

Beyond the acquisition of the strategic stake in Polarise, SWI Group has committed a further EUR 1.0 billion towards the partnership’s site pipeline expansion and buildout that will create cutting-edge AI factories powered by NVIDIA’s latest GPUs. The EUR 1bn commitment reflects SWI’s conviction in the structural growth of AI compute demand in Europe and the need for well-capitalised, integrated platforms to serve it. This allocation will enable the activation of each party’s respective pipelines, granting Polarise the capital towards the execution of already secured acquisitions, while empowering SWI to convert its opportunity set with stronger dedication due to higher control over the future operational element.

Max-Hervé George, Founder and CEO of SWI Group comments: “We are extremely excited about partnering up with such an esteemed player in the GPU- and AI-as-a-Service business, allowing us to extend our existing investment in data centers to encompass the critical operating elements pertaining to GPU compute and client interface. Our ambition targets the creation of the foremost digital infrastructure developer and operator in Europe. We cannot imagine a better way to do it than with the extraordinary team at Polarise.”

Michel Boutouil, Founder and CEO of Polarise, further states: “The partnership with SWI Group will allow us to significantly accelerate our mission and reach new frontiers within a much shorter period of time – precious time that Europe needs to recoup in the global AI race. Having such a solid funding commitment from a partner that precisely understands our ambitions, along with a vast existing power supply across strategic European locations, is a great basis for the further development of much-needed digital infrastructure in Europe.”

Together, SWI Group, AiOnX and Polarise are building an integrated European AI infrastructure platform spanning power, compute and delivery.”

This press release contains or may contain inside information within the meaning contemplated by the EU Market Abuse Regulation (596/2014).

Notes to Editors

About SWI Group

SWI Stoneweg Icona Group (www.swi.com), listed on the Amsterdam Euronext Stock Exchange under SWICH (Isin: SGXPZ11CH7U7), is an alternative investment conglomerate driven by a strong entrepreneurial spirit that operates in numerous sectors, including Data Centers, Real Estate, Credit, and the Financial Sector.  The company’s investment strategies are grounded in thorough research, in-depth first-hand knowledge, and the ability to efficiently implement strategies to maximise the greatest return potential.

Within digital infrastructure, the Group is active in the development, acquisition, and management of data center assets through AiOnX. The Group’s approach in this area spans the full investment cycle—from sourcing and development to construction and operations, aiming to build high-quality, income-generating infrastructure over time. The group currently owns five data center sites across Europe, in Ireland, UK, Denmark, Spain, and Italy.

SWI Group relies on local operating teams to identify, develop and manage opportunities around the world, both real estate and investment strategies. SWI Group has approximately EUR 11 billion of assets under management and roughly 300 employees across 26 offices across the world.

About Polarise GmbH

Founded in Germany, Polarise (www.polarise.eu) is a leading European AI infrastructure platform delivering high-performance computing (HPC) at scale through a combination of purpose-built AI data centres, advanced software capabilities and deep operational expertise. As one of Europe’s preferred NVIDIA Cloud Partner and NVIDIA Cloud Service Provider, Polarise enables enterprise and sovereign customers to deploy mission-critical AI workloads with high performance, security and reliability across the continent.

Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China

By
Advertorial Desk
-

  • UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk
  • In a placebo-controlled phase 2 trial in Chinese people with overweight or obesity, UBT251 led to a statistically significant mean weight loss of up to 19.7% after 24 weeks
  • UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies.

GUANGDONG, CHINA & BAGSVÆRD, DENMARK – Media OutReach Newswire – 24 February 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G).

UBT251 is being jointly developed by TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology) and Novo Nordisk under an agreement signed in March 2025. United Biotechnology is responsible for development in Chinese mainland, Hong Kong, Macau and Taiwan, while Novo Nordisk is responsible for development in the rest of the world.

The trial, conducted by United Biotechnology, investigated the safety and efficacy of once-weekly injectable 2 mg, 4 mg and 6 mg doses of UBT251 compared to placebo in Chinese people with overweight or obesity. From a baseline mean body weight of 92.2 kg, the highest mean weight loss observed for people treated with UBT251 was 19.7% (-17.5 kg) compared to 2.0% (-1.6kg) in the placebo group after 24 weeks of treatment[i].

Moreover, all dose groups of UBT251 showed statistically significant improvements relative to placebo on key secondary endpoints, including waist circumference, blood glucose, blood pressure and lipids.

In the trial, UBT251 appeared to have a safe and well-tolerated profile. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate and diminished over time, consistent with incretin-based therapies.

“The success of the phase 2 clinical trial of UBT251 in China represents another significant milestone in TUL’s innovation-driven development,” said Mr Tsoi Hoi Shan, Chairman of TUL. “We will continue to focus on chronic diseases, including endocrine and metabolic disorders, accelerate the further development of UBT251, and strive to bring more high-quality treatment options to patients worldwide at the earliest opportunity.”

“We are very encouraged by these data from the trial in China, which demonstrate the potential of UBT251 and its differentiated clinical profile and safety and tolerability profile,” said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk. “We look forward to reporting data from a global trial with UBT251 conducted by Novo Nordisk next year.”

Novo Nordisk recently initiated a global phase 1b/2a trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of different doses of UBT251 for up to 28 weeks in around 330 people living with overweight or obesity. Topline data from that trial is expected in 2027. Novo Nordisk also expects to initiate a phase 2 trial with UBT251 in people with type 2 diabetes in the second half of 2026.

United Biotechnology will present detailed data from the Chinese phase 2 trial at a medical congress later this year. Based on the results of this trial, the company is planning to initiate a phase 3 trial in Chinese patients with overweight or obesity.

About the Chinese phase 2 trial

This randomized, double-blind, placebo-controlled trial enrolled a total of 205 Chinese patients with obesity (BMI ≥ 28.0 kg/m²) or overweight (24.0 kg/m² ≤ BMI < 28.0 kg/m²) with at least one weight-related comorbidity. The baseline mean body weight of the patients was 92.2 kg, with a baseline mean BMI of 33.1 kg/m². Patients were randomly assigned to receive weekly subcutaneous injections of UBT251 in doses of 2 mg, 4 mg, 6 mg, or placebo for 24 weeks. The primary endpoint of the trial was the percentage change in body weight from baseline after 24 weeks of treatment. About UBT251

UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon.

In March 2025, United Biotechnology entered an exclusive license agreement with Novo Nordisk A/S for UBT251. Under the agreement, Novo Nordisk obtained exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture and commercialise UBT251. United Biotechnology retained the rights for UBT251 in Chinese mainland, Hong Kong, Macau and Taiwan.

[i] Based on the efficacy estimand according to the trial protocol, regardless of dose modification

Hashtag: #UBT251

The issuer is solely responsible for the content of this announcement.

About TUL and United Biotechnology

Founded in 1990, TUL (HKEX: 3933) is mainly engaged in the research and development, production and sales of pharmaceuticals, and ranks among the leading integrated pharmaceutical companies in China. TUL currently boasts seven production bases, covering intermediate products, bulk medicine, finished products, veterinary drugs, empty capsule casings, and medical devices, with the sales networks dotted across nearly 80 countries and regions. United Biotechnology, located in the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, serves as the biopharmaceutical R&D headquarter of TUL. United Biotechnology focuses on the development of high-end biopharmaceuticals to treat major chronic diseases. For more information, please visit .

About Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. For more information, visit , , , , and .

Only 6% of Marketers Have Fully Implemented AI, According to New Supermetrics Report

By
Advertorial Desk
-

HELSINKI, Feb. 24, 2026 /PRNewswire/ — Supermetrics, the Marketing Intelligence Platform trusted by thousands of marketing teams, today released its 2026 Marketing Data Report based on a global survey of marketers at leading brands and agencies.

Supermetrics Marketing Data Report 2026
Supermetrics Marketing Data Report 2026

The report finds that leadership urgency around AI continues to rise, with 80% of marketers feeling pressure to adopt AI. Yet only 6% have fully implemented it in their workflows, due to limited data access and trust in AI. Pressure comes largely from the top, with respondents attributing 89% of AI adoption pressure to the C-suite and board.

That pressure lands squarely on marketing teams who lack control over the very data foundations AI requires. More than half of respondents (52%) said external teams define their data strategy and measurement, while 50% wait 1–3 business days for data team support and just 7% receive real-time support.

In that environment, trust and clarity inevitably suffer. Only 18% reported high trust in AI, 37% lacked a clear AI strategy from leadership, and 39% expressed concerns about AI data privacy. Financial strain deepens the challenge as 55% of marketers face pressure to cut costs while maintaining results, and nearly four in ten still struggle to prove ROI across channels, heightening scrutiny on every marketing dollar.

“AI can accelerate marketing performance, but only if the data behind it is strong,” said Anssi Rusi, CEO of Supermetrics. “When marketing teams have clean, structured, and up-to-date data at their fingertips, they can move beyond testing and start making AI-powered decisions with real business impact.”

Trusted by brands including BBC, Heineken, Levi’s and L’Oréal,Supermetrics helps marketers strengthen their data foundations, reduce manual reporting, and move from fragmented insights to real-time activation. The 2026 Marketing Data Report underscores the need for unified data, clearer ownership, and measurable outcomes, areas where organizations must invest before scaling AI. By connecting data across systems and enabling faster, more reliable decision-making, Supermetrics equips marketing teams to close the gap between AI ambition and measurable performance.

For the full Supermetrics 2026 Marketing Data Report, click here.  

About Supermetrics

Supermetrics is a marketing intelligence platform that helps organizations move from understanding past performance to driving future action. Trusted by more than 200,000 companies in 120 countries, Supermetrics unifies the marketing intelligence workflow from data connectivity to insight to activation, enabling confident, revenue-focused decisions. Founded in 2013 and headquartered in Helsinki, the company employs more than 400 people across offices in Helsinki, Dublin, and Singapore, with teams spanning APAC, Europe, and North America. Processing 15% of global advertising spend, Supermetrics helps brands and agencies navigate marketing with confidence in today’s evolving data landscape. Learn more at www.supermetrics.com

Media Contact:
Devonne Spence
Supermetrics
devonne.spence@supermetrics.com

Photo: https://laotiantimes.com/wp-content/uploads/2026/02/supermetrics_report_2026.jpg
Photo: https://laotiantimes.com/wp-content/uploads/2026/02/supermetrics_anssi_rusi.jpg
Logo: https://laotiantimes.com/wp-content/uploads/2026/02/supermetrics_logo.jpg

 

Anssi Rusi, CEO, Supermetrics
Anssi Rusi, CEO, Supermetrics

 

 

MOPIC Launches ‘HoloGlass,’ Turning iPhone Screens into Glasses-Free 3D with a Single Attachment

By
Advertorial Desk
-

SEOUL, South Korea, Feb. 24, 2026 /PRNewswire/ — MOPIC Co., Ltd., a glasses-free 3D technology company, has launched ‘HoloGlass,’ a screen protector-type 3D solution with an integrated 3D lens that transforms smartphone screens into immersive glasses-free 3D. HoloGlass is supplied to business partners, enabling them to deliver glasses-free 3D experiences to end users.

Hybrid structure solves ‘2D image degradation’… Full lineup established up to iPhone 17

The key feature of ‘HoloGlass’ is its hybrid structure, based on MOPIC’s proprietary ultra-precise 3D lens design technology. This structure preserves full-resolution 2D image quality during normal use and seamlessly enables immersive glasses-free 3D when the dedicated app is activated.

HoloGlass is available for the iPhone 14, 15, and 16 series, as well as the latest iPhone 17 series, providing a complete lineup.

Real-time 3D conversion for 2D YouTube videos… World’s first ‘real-time 3D preview’ support

The dedicated app ‘MOPIC’ provides real-time 3D conversion not only for existing 3D content but also for photos and videos shot with smartphones, as well as streaming platforms such as YouTube.

It also supports the world’s first ‘Real-time 3D Preview’ feature, allowing users to view the smartphone camera’s live feed in stereoscopic 3D in real time. This enables intuitive 3D content creation without the need for expensive professional equipment.

Samsung Electronics-backed technology accelerates global B2B market expansion

MOPIC, a spin-off from Samsung Electronics’ internal venture (C-Lab) in 2015, has established strong technological capabilities, including in-house development of glasses-free 3D hardware and image processing algorithms. Building on this foundation, the company is currently supplying SDKs (Software Development Kits) featuring real-time conversion and 3D preview technology to global telecommunications companies, OTT providers, and game developers, while expanding collaborations.

A MOPIC representative stated, “HoloGlass is the optimal solution enabling companies to introduce glasses-free 3D services at a reasonable cost,” adding, “We expect it to drive the popularization of 3D content across various industries, as it allows users to experience 3D technology at a cost comparable to protective glass.”

MOPIC also announced its participation in the Global Sources Hong Kong exhibition this April 2026 (Booth 7P02), where it will actively pursue partnerships with global distributors and industry partners.

Learn more at : www.mopiclabs.com 

Address : 1104 & 1105 – B Building, 66 Beolmal-Ro, Dongan-Gu, Anyang-Si, Gyeonggi-Do 14058, Korea

Media Contact

Company name : MOPIC Co., Ltd.

Contact person : Jeesoo Jung

Email : info@mopic.co.kr

Fat or Skinny Fat: Both Can Harm Your Health | Join the Anti-Obesity Health Base: Outsmart the Obesity Threat Together

By
Advertorial Desk
-

HONG KONG, Feb. 24, 2026 /PRNewswire/ — Hong Kong is a world-renowned food paradise, offering everything from local snacks like fish balls and egg waffles to Michelin-starred culinary experiences. However, maintaining a healthy weight amidst fast-paced lifestyles, high pressure, and even genetic factors has become a relentless battle. Excessive fat accumulation poses significant health risks, and even those with a seemingly slender physique can fall into the trap of obesity. Today, obesity is no longer just a cosmetic concern; it is classified as a chronic, relapsing disease by the World Health Organization (WHO). Thus, weight loss and anti-obesity measures are now essential strategies for preserving health, not just for aesthetic reasons.


To deepen public understanding of the health threats posed by obesity, Novo Nordisk Hong Kong—driven by its commitment as a leader and pioneer in obesity management—is proud to support the “Anti-Obesity Health Base” campaign. This event offers the public the opportunity to learn about their true weight health status, while also understanding the associated harms and complications of obesity through engaging virtual games and informative exhibits. Adding a unique layer of local charm, the campaign features exclusive illustrations by the beloved homegrown illustrator brand “Maggiemarket.” From interactive games and photo spots to the exhibition zones, Maggiemarket’s playful characters will be there to guide and entertain participants throughout the entire experience.

Anti-Obesity Health Base
Location: Atrium, K11 Art Mall, 18 Hanoi Rd, Tsim Sha Tsui
Opening Hours: February 24 (TUE) to March 4 (WED), 2026, from 12 PM to 8 PM
Event Highlights:

  • Maggiemarket photo spots
  • Body mass index (BMI) & waist measurement station
  • Interactive games, exciting prizes, and an instant photo booth
  • Complimentary anti-obesity four-frame photo booth experience*
  • Souvenir giveaways, including anti-obesity motivational keychains*
    *Limited quantities available; first-come, first-served until supplies last

How Common is Obesity in Hong Kong?
Obesity is a widespread issue in Hong Kong and around the world. According to the Department of Health, over half of the local population aged 15 and above are classified as overweight or obese, with approximately 44% of those aged 25 to 34 and over 61% in middle age[1]. In Hong Kong, an adult is considered overweight with a BMI of 23 to 25, while a BMI over 25 classifies them as obese[2].

Additionally, central obesity can occur even with a normal BMI. Waist circumference is a key indicator: a measurement of 90 cm (35.4 inches) or more for men, or 80 cm (31.5 inches) or more for women, may signal obesity risks[4] & [6].

Globally, the scale is immense. WHO data shows that over 2.5 billion adults are overweight or obese, a condition that also affects nearly 450 million children and adolescents aged 5 to 19[3].

Why Should Obesity Be Addressed as a Disease?
Many dismiss obesity as merely an issue of appearance, but it is often the root of numerous health issues. Increasing evidence shows that obese individuals are at a higher risk for several conditions, including hypertension, arthritis, fatty liver, diabetes, dyslipidemia, chronic kidney disease, sleep apnea, metabolic syndrome, and even multiple types of cancer[4] & [5]. The global toll is severe: in 2021 alone, high BMI was linked to 3.7 million deaths worldwide[3].

Moreover, obesity imposes a heavy psychological and functional burden. It can lead to breathing difficulties, mobility issues, back pain, sleep disorders, fatigue, reduced productivity, depression, and anxiety[5]—impeding daily life, work, and social interactions.

Why Is Weight Control Crucial for Health?
Weight gain is often the result of an imbalance between calorie intake and expenditure, influenced by a complex mix of genetic, environmental, psychological, and social factors[3].

Since obesity arises from multiple factors, simply dieting and exercising may not be sufficient to overcome it. Seeking professional medical advice can help achieve effective and targeted weight management. WHO has also included safe and effective pharmacotherapy as one of the recommended options within comprehensive obesity management guidelines[3].

Join the Anti-Obesity Health Base Together!
Supported by Novo Nordisk Hong Kong, the Anti-Obesity Health Base aims to raise awareness of obesity and encourage everyone to fight against it!

The Anti-Obesity Health Base is divided into various zones, offering a range of activities and information:

  • BMI & Waist Measurement Station: Even if you appear slim, the results may surprise you! Let’s find out if you’re at risk. Get your BMI and waist circumference measured to reveal hidden risks like central obesity that aren’t visible.
  • Interactive Games (Pedaling in Place & “Weight No More” Health Defender): Understand how obesity is linked to serious diseases. Play our immersive virtual games to battle obesity-related health risks and learn about the various conditions it can cause.
  • “Guess Who Has Obesity?” Exhibition: Listen to personal stories from different patients. Guess who is obese, challenging the assumption that health status can be judged by appearance alone.
  • Giant Capsule Toy Machine: Discover the real impact of obesity on physical and mental health through educational videos. Try your luck at the capsule toy machine to win prizes like keychains featuring our “Anti-Obesity” slogans.
  • Maggiemarket Photo Spots: Capture the moment with a complimentary four-frame photo at our themed booth. Limited quantities available, first-come, first-served.

The Anti-Obesity Health Base is all set and invites everyone to join us. It’s time to truly understand obesity, recognize your personal risks, and take proactive steps to tackle obesity for your health!

References

1. Department of Health. Report of Population Health Survey 2020-22 (Part II).

2. CHP. Obesity. https://www.chp.gov.hk/en/healthtopics/content/25/8802.html 

3. WHO. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight 

4. WHO Western Pacific Region. The Asia-Pacific perspective: Redefining obesity and its treatment. https://iris.who.int/server/api/core/bitstreams/53228dc6-9520-421b-b5a2-f826967090cb/content 

5. NHS. Obesity. https://www.nhs.uk/conditions/obesity/

6. The IDF consensus worldwide de­finition of the Metabolic Syndrome. https://idf.org/media/uploads/2023/05/attachments-30.pdf

 

 

Haulla Reduces Waste Costs Across North America with Digital Platform Innovations, Expands to 70+ Markets

By
Advertorial Desk
-

SEOUL, South Korea, Feb. 24, 2026 /PRNewswire/ — Waste management platform Haulla is maintaining a steep growth trajectory, positioning its core value proposition around cost-efficiency and digital-first accessibility.

Founded with the ambition to rectify excessive and imbalanced pricing in the waste sector, Haulla’s primary goal is to ensure that customers pay only for the services they truly require. To achieve this, the platform utilizes a sophisticated, data-driven matching system. By analyzing a customer’s geographic location, business vertical, waste volume, and specific service needs, Haulla connects them with optimized local haulers and offers a rationalized pricing structure. This allows businesses to bypass the industry’s notoriously high surcharges and select services tailored to their actual needs.

Solving Structural Inefficiencies with Tech

Haulla is particularly focused on resolving ‘Missed Pick-up’ issues, a frequent headache in the commercial waste market. Using its proprietary fill-level sensor CFX and their cloud based platform CCN. Haulla monitors dumpster capacity in real-time.

Rather than relying on arbitrary schedules, the system sends collection alerts only when containers reach a pre-set threshold. This significantly increases operational efficiency by eliminating unnecessary hauls for containers that aren’t yet full. Furthermore, it proactively prevents safety risks associated with overfilling and provides a fully integrated digital audit trail of all collection data.

Dominating the North American Market

Providing price competitiveness with a tech-driven operating model, Haulla has established itself as a premier success story in the digital waste management space. Haulla now operates in nearly every U.S. state, recently expanding over 70 major markets across the country. With an upcoming expansion into Vancouver, Canada, Haulla is now accelerating its footprint across the entire North American continent.

“We are positioning ourselves as a digital platform that manages the entire lifecycle of commercial waste through sensor technology and data,” said a representative from Haulla. “Our goal is to lead market change by eliminating structural inefficiencies—such as the missed pick-up problem, excessive surcharging, and opaque contracts—that have plagued this industry for too long.”

Learn more at : https://www.haulla.com/

Address : 508 Monterey Pass Rd Unit B, Monterey Park, California, USA

Media Contact

Company name : HAULLA
Contact person : James Noh
Email : support@haulla.com

 

Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture

By
Advertorial Desk
-

SINGAPORE, Feb. 24, 2026 /PRNewswire/ — Klook, a leading pan-regional experiences platform in Asia Pacific, today announces the signing of a Memorandum of Understanding (MoU) with the Osaka Convention & Tourism Bureau (OCTB).

Left to right: Hiroshi Mizohata, Chairman of the Osaka Convention & Tourism Bureau and Wataru Masuda, General Manager, Klook Japan
Left to right: Hiroshi Mizohata, Chairman of the Osaka Convention & Tourism Bureau and Wataru Masuda, General Manager, Klook Japan

This collaboration reflects a broader shift toward discovery-led destination development, bringing together Klook’s data and digital infrastructure with OCTB’s on-the-ground expertise to shape how travelers experience Osaka beyond its city center.

Under the MoU, Klook and OCTB will collaborate on joint content development and online promotions, mutual data sharing and analysis to better understand inbound travel behavior, sustainable tourism initiatives aimed at managing visitor flows, and deployment of digital solutions to enhance traveler convenience and support local tourism stakeholders.

“Osaka tourism is currently at a structural turning point. Beyond simply increasing visitor numbers, it is essential to create experiential value across the entire prefecture and to pursue continuous improvement based on data. This partnership aims to refine the unique strengths of each municipality into market-ready products and to create an environment in which travelers can more easily discover new and exciting experiences. By combining Klook’s market data and expertise with OCTB’s research capabilities and regional knowledge, we will work together to build effective strategies that achieve both broader economic impact and sustainable growth,” says Hiroshi Mizohata, Chairman of the Osaka Convention & Tourism Bureau.

From Gateway City to Regional Ecosystem

Insights from Klook’s Travel Pulse 2026, an annual study surveying 11,000 travelers across 20 markets, signal strong global momentum behind Osaka.

Among travelers who have selected Japan as their must-visit destination in 2026, 48.6% plan to include Osaka in their itinerary. Intent is stronger among Millennials (53.4%), outpacing Gen Z travelers (43.5%). Given Millennials’ higher spending power, this signals positive momentum for tourism spending in Osaka.

Osaka is evolving not only as a destination in its own right, but increasingly as a key gateway connecting travelers to surrounding regions.

Klook’s owned platform data over the past 12 months reinforces this shift, with mobility-related bookings — from JR Kansai passes and Shinkansen tickets to car rentals — as one of the top categories in Japan. This suggests that inbound travelers are exploring the destination more extensively.

Together, these signals point to a broader evolution in travel behavior: major cities are becoming launchpads for multi-destination journeys, underscoring the growing importance of regional connectivity and curated experiences across prefectural areas.

Advancing Digital Transformation and Sustainable Growth

Beyond marketing collaboration, the MoU reflects a broader shift toward digital-first destination management. Initiatives under the partnership will explore new technologies, including digital content solutions and audio guide capabilities, to enhance the visitor journey while supporting local businesses as they adapt to evolving travel behaviors.

“At Klook, we see platforms as infrastructure for discovery. Insights from Travel Pulse show that travelers are moving beyond single-city itineraries, and partnerships like this allow us to translate those signals into real-world experiences,” says Wataru Masuda, General Manager, Klook Japan.

“Working closely with OCTB enables us to connect data, technology, and storytelling to help travelers explore Osaka more thoroughly, while supporting small and medium-sized merchants beyond Osaka City in reaching global travelers through Klook’s platform.”

“By amplifying discovery of experiences across the wider prefecture, we aim to encourage more balanced visitor flows that benefit local communities,” he says.

As destinations increasingly look toward distributed growth, collaborations between technology platforms and tourism organizations are becoming essential in shaping travel flows — using data and discovery to distribute demand more sustainably across regions.

About Osaka Convention & Tourism Bureau

The Osaka Convention & Tourism Bureau (OCTB) is a regional Destination Management Organization (DMO) supported by Osaka Prefecture, Osaka City, Sakai City, and the Kansai business community. Certified by the Japan Tourism Agency in 2016, OCTB leads tourism promotion across Osaka under an “All Osaka” framework.

OCTB is responsible for developing and implementing tourism strategies grounded in strategic marketing and data-driven insights. By identifying, enhancing, and promoting tourism assets throughout the prefecture, OCTB works closely with municipalities, tourism operators, transportation providers, and industry partners to build a sustainable, high-value tourism model.

In addition, OCTB strengthens Osaka’s international competitiveness through MICE promotion and the development of tourism-related information infrastructure.

About Klook

Klook is a leading pan-regional experiences platform in Asia Pacific, purpose built to digitalize experiences and make them accessible to every traveler. Our mission is to build the digital infrastructure for the global experience economy — empowering merchants to share their passions and travelers to discover the heartbeat of each destination. We operate a mobile-first, curated platform featuring diverse experiences across global destinations.

Notice of the Annual General Meeting of shareholders 2026 of Telefonaktiebolaget LM Ericsson

By
Advertorial Desk
-

STOCKHOLM, Feb. 24, 2026 /PRNewswire/ — The shareholders of Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) (reg. no 556016-0680) (the “Company” or “Ericsson“) are invited to participate in the Annual General Meeting of shareholders (“AGM“) to be held on Tuesday, March 31, 2026 at 2:00 PM CEST at the Company’s premises: Open Box, Grönlandsgatan 8, Kista/Stockholm. Registration for the AGM starts at 1:00 PM CEST. Shareholders may also exercise their voting rights by post before the AGM.

The AGM will be conducted in Swedish and simultaneously translated into English.

Registration and notice of participation

A) Participation at the meeting venue

Shareholders who wish to attend the meeting venue in person or by proxy must:

  • be recorded as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB, as of Monday, March 23, 2026; and   
  • give notice of participation to the Company no later than Wednesday, March 25, 2026               
    • by telephone +46 (0)8 402 90 54 on weekdays between 10:00 AM and 4:00 PM CET;
    • by post to Telefonaktiebolaget LM Ericsson, AGM, c/o Euroclear Sweden AB, Box 191, SE-101 23 Stockholm, Sweden;
    • by e-mail to GeneralMeetingService@euroclear.com; or
    • via Ericsson’s website www.ericsson.com/en/agm.

When giving notice of participation, please include name, date of birth or registration number, address, telephone number and number of participating assistants, if any.

Proxy
If the shareholder is represented by proxy, a written and dated power of attorney signed by the shareholder must be issued for the representative. A power of attorney issued by a legal entity must be accompanied by the entity’s certificate of registration (or a corresponding document of authority). In order to facilitate registration at the AGM, the power of attorney, certificate of registration and other documents of authority should be sent to the Company at the address above, in connection with the notice of participation. Forms of power of attorney in Swedish and English are available on Ericsson’s website, www.ericsson.com/en/agm.

B) Participation by postal voting

Shareholders who wish to participate in the AGM by postal voting must:

  • be recorded as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB, as of Monday, March 23, 2026; and
  • give notice of participation by casting its postal vote in accordance with the instructions below, so that the postal voting form is received by Euroclear Sweden AB no later than Wednesday, March 25, 2026.

A special form must be used for postal voting. The form is available on Ericsson’s website www.ericsson.com/en/agm. The completed and signed postal voting form may be sent by post to Telefonaktiebolaget LM Ericsson, AGM, c/o Euroclear Sweden AB, Box 191, SE-101 23 Stockholm, Sweden, or by e-mail to GeneralMeetingService@euroclear.com. Shareholders may also submit their postal votes electronically by verification with BankID via Ericsson’s website, www.ericsson.com/en/agm. The completed form must be received by the Company/Euroclear Sweden AB no later than Wednesday, March 25, 2026.

The shareholder may not provide special instructions or conditions in the postal voting form. If such instructions or conditions are included, the postal vote (in its entirety) is invalid. Further instructions and conditions are included in the form for postal voting.

If the shareholder submits its postal vote by proxy, a written and dated power of attorney signed by the shareholder must be attached to the postal voting form. If the shareholder is a legal entity, the entity’s certificate of registration (or a corresponding document of authority) must be attached to the form. Forms of power of attorney in Swedish and English are available on Ericsson’s website, www.ericsson.com/en/agm.

A shareholder who has voted by post may also attend the meeting venue, provided that the notification has been made in accordance with the instructions under the heading Registration and notice of participation – A) Participating at the meeting venue above.

Shares registered in the name of a nominee
In order to be entitled to participate in the AGM, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of participation in the AGM, register its shares in its own name so that the shareholder is listed in the presentation of the share register of the Company as of Monday, March 23, 2026. Such re-registration may be temporary (so-called voting rights registration), and request for such voting rights registration shall be made to the nominee, in accordance with the nominee’s procedures, at such a time in advance as required by the nominee.

Voting rights registrations that have been made by the nominee on or before Wednesday, March 25, 2026 will be considered in the presentation of the share register.

Processing of personal data
For information regarding the processing of personal data in connection with the AGM, please see the privacy policy on Euroclear Sweden AB’s website: https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf

If you have questions regarding Ericsson’s processing of your personal data, you can contact the Company by emailing ericsson.group.privacy@ericsson.com. Ericsson has company registration number 556016-0680 and the Board’s registered office is in Stockholm.

Proposed agenda

  1. Election of the Chair of the AGM
  2. Preparation and approval of the voting list
  3. Approval of the agenda of the AGM         
  4. Determination whether the AGM has been properly convened             
  5. Election of two persons approving the minutes of the AGM
  6. Presentation of the annual report, the auditor’s report, the consolidated accounts, the auditor’s report on the consolidated accounts, the auditor’s limited assurance report over the group sustainability statement, the remuneration report and the auditor’s report on whether the guidelines for remuneration to group management have been complied with, as well as the auditor’s presentation of the audit work with respect to 2025           
  7. The President and CEO’s speech. Questions from the shareholders to the Board of Directors and the management    
  8. Resolution with respect to
                8.1. adoption of the income statement and the balance sheet, the consolidated income statement and the      consolidated balance sheet; 
                8.2. adoption of the remuneration report;
                8.3. discharge of liability for the members of the Board of Directors and the President 2025; and
                8.4. the appropriation of the results in accordance with the approved balance sheet and determination of the record dates for dividend 
  9. Determination of the number of Board members and deputies of the Board of Directors to be elected by the AGM
  10. Determination of the fees payable to members of the Board of Directors elected by the AGM and members of the Committees of the Board of Directors elected by the AGM
  11. Election of Board members and deputies of the Board of Directors
                The Nomination Committee’s proposal for Board members:
                11.1. Jon Fredrik Baksaas (re-election)
                11.2. Jan Carlson (re-election)
                11.3. Christian Cederholm (re-election)
                11.4. Börje Ekholm (re-election)
                11.5. Eric A. Elzvik (re-election)
                11.6. Marachel Knight (re-election)
                11.7. Kristin S. Rinne (re-election)
                11.8. Jonas Synnergren (re-election)
                11.9. Jacob Wallenberg (re-election)
                11.10. Christy Wyatt (re-election)
                11.11. Karl Åberg (re-election)
  12. Election of the Chair of the Board of Directors
  13. Determination of the number of auditors
  14. Determination of the fees payable to the auditors
  15. Election of auditors 
  16. Long-Term Variable Compensation Program 2026 (LTV 2026)
                16.1. Resolution on implementation of the LTV 2026
                16.2. Resolution on transfer of treasury stock to employees and on an exchange, for the LTV 2026
                16.3. Resolution on Equity Swap Agreement with third party in relation to the LTV 2026 
  17. Amendment of the terms of the Long-Term Variable Compensation Program 2025 (LTV 2025)
                17.1. Resolution on amendment of the terms for the LTV 2025
                17.2. Resolution on transfer of treasury stock to employees and on an exchange for the LTV 2025
                17.3. Resolution on Equity Swap Agreement with third party in relation to the LTV 2025
  18. Authorizations on transfer of treasury stock in relation to the resolutions on the ongoing Long-Term Variable Compensation Programs LTV I 2023, LTV II 2023 and LTV 2024
                18.1. Authorization to decide on transfer of treasury stock on an exchange to cover expenses
                18.2. Authorization to decide on transfer of treasury stock on an exchange to cover costs for tax and social security liabilities for the Participants
  19. Authorization for the Board of Directors to decide upon purchase of own shares
  20. Closing of the AGM

For the full notice and more information, see attachment or visit www.ericsson.com/en/agm.

NOTES TO EDITORS:

FOLLOW US:

Subscribe to Ericsson press releases here
Subscribe to Ericsson blog posts here
https://twitter.com/ericsson
https://www.facebook.com/ericsson
https://www.linkedin.com/company/ericsson

MORE INFORMATION AT:
Ericsson Newsroom
media.relations@ericsson.com  (+46 10 719 69 92)
investor.relations@ericsson.com  (+46 10 719 00 00)

ABOUT ERICSSON:
Ericsson’s high-performing networks provide connectivity for billions of people every day. For 150 years, we’ve been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/ericsson/r/notice-of-the-annual-general-meeting-of-shareholders-2026-of-telefonaktiebolaget-lm-ericsson,c4311175

The following files are available for download:

https://mb.cision.com/Main/15448/4311175/3947715.pdf

Notice of the Annual General Meeting of shareholders 2026 of Telefonaktiebolaget LM Ericsson

https://mb.cision.com/Public/15448/4311175/b0e7df88adb7ae86.pdf

Full Notice of the Annual General Meeting of shareholders 2026 of Telefonaktiebolaget LM Ericsson

 

1...1,0981,0991,100...6,605Page 1,099 of 6,605